Germany's Merz Pharmaceuticals to acquire BioForm Medical for $253 million domain-B It is a leader in treating Alzheimer's, Parkinson's and depression, and has made rapid advances in anti-ageing skin care. Merz's flagship molecule is ... |
Sunday, January 3, 2010
Germany's Merz Pharmaceuticals to acquire BioForm Medical for $253 million - domain-B
Read More
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.